Concepedia

Publication | Closed Access

Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

463

Citations

24

References

2007

Year

Abstract

Both in vivo costimulation and repeated administration enhance eradication of systemic tumor by genetically targeted T cells. The finding that modifications in CAR design as well as T-cell dosing allowed for the complete eradication of systemic disease affects the design of clinical trials using this treatment strategy.

References

YearCitations

2002

997

2004

806

2003

655

1998

532

2005

484

2006

481

2004

450

2002

444

1995

370

2001

352

Page 1